Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
93.06 USD | +1.56% | -2.34% | -4.23% |
05-21 | Banks push Australia shares down; James Hardie dips to 5-month low | RE |
05-17 | Australia shares retreat as banks, technology, healthcare stocks drag | RE |
Chart calendar CSL Limited
Upcoming events on CSL Limited
Past events on CSL Limited
2024-04-05 | American College of Cardiology Scientific Meeting |
2024-03-10 | Ex-dividend day for dividende intermédiaire |
2024-02-12 | Q2 2024 Earnings Call |
2024-02-12 16:24 | Q2 2024 Earnings Release |
2023-10-15 18:15 | Capital Markets Day |
2023-10-10 19:00 | Annual General Meeting |
2023-10-10 | IDWeek Conference |
2023-09-10 | Final dividend |
2023-08-14 21:00 | Q4 2023 Earnings Call |
2023-08-14 18:30 | Q4 2023 Earnings Release |
2023-06-13 | Business Update Call |
2023-05-28 | Shareholders Meeting |
2023-04-25 13:50 | Canadian Immunization Conference |
2023-03-08 | Ex-dividend day for dividende intermédiaire |
2023-02-23 | American Academy of Allergy, Asthma & Immunology Meeting |
2023-02-13 | Interim 2023 Earnings Call |
2023-02-13 16:10 | Interim 2023 Earnings Release |
2022-11-02 18:00 | R&D Day |
2022-10-16 19:00 | Investor Meeting |
2022-10-11 19:00 | Annual General Meeting |
Past dividends on CSL Limited
2024-03-10 | Interim Payment 1.798942 AUD |
2023-09-10 | Final Payment 1.8070038 AUD |
2023-09-10 | Final Payment 0.2007782 AUD |
2023-03-08 | Interim Payment 1.621458 AUD |
2022-09-05 | Final Payment 0.1758307 AUD |
2022-09-05 | Final Payment 1.5824763 AUD |
2022-03-06 | Interim Payment 1.422903 AUD |
2021-09-01 | Final Payment 1.4306886 AUD |
2021-09-01 | Final Payment 0.1589654 AUD |
2021-03-03 | Interim Payment 1.349073 AUD |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 8 539 8 493 0.53% | 9 151 9 224 -0.79% | 10 310 10 095 2.13% | 10 562 10 722 -1.49% | 13 310 13 344 -0.25% | 14 717 |
EBITDA Million USD | Released Forecast Spread | 2 879 2 911 -1.07% | 3 136 3 204 -2.11% | 3 720 3 589 3.64% | 3 596 3 498 2.8% | 3 900 4 259 -8.43% | 4 905 |
EBIT Million USD | Released Forecast Spread | 2 504 2 575 -2.76% | 2 717 2 781 -2.33% | 3 130 3 104 0.85% | 2 927 2 946 -0.64% | 3 069 3 546 -13.45% | 4 198 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 341 2 420 -3.27% | 2 573 2 651 -2.97% | 2 963 3 000 -1.22% | 2 780 2 782 -0.1% | 2 663 3 050 -12.68% | 3 642 |
Net income Million USD | Released Forecast Spread | 1 919 1 908 0.57% | 2 103 2 115 -0.61% | 2 375 2 321 2.34% | 2 255 2 255 -0.03% | 2 194 2 258 -2.85% | 2 711 |
EPS USD | Released Forecast Spread | 4,23 4,21 0.43% | 4,62 4,65 -0.84% | 5,21 5,09 2.28% | 4,80 4,79 0.25% | 4,53 4,65 -2.65% | 5,65 |
Announcement Date | 13/08/19 | 18/08/20 | 17/08/21 | 16/08/22 | 14/08/23 | - |
Quarterly results
Fiscal Period | June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 911 4 821 1.87% | 4 240 4 347 -2.45% | 5 739 5 569 3.04% | 4 571 4 366 4.7% | 6 041 5 879 2.76% | 4 521 4 682 -3.44% | 7 184 7 250 -0.91% | 6 127 6 134 -0.13% | 8 053 8 016 0.46% | 6 574 | 8 662 | 7 234 |
EBITDA Million USD | Released Forecast Spread | 1 836 1 896 -3.14% | 1 300 1 281 1.48% | 2 638 2 148 22.83% | 1 081 922 17.25% | 2 479 2 342 5.87% | 1 117 1 048 6.53% | 2 516 2 386 5.44% | 1 384 1 545 -10.4% | 3 042 3 082 -1.3% | 2 146 | ||
EBIT Million USD | Released Forecast Spread | 1 632 1 689 -3.38% | 1 085 1 079 0.51% | 2 358 1 923 22.62% | 772 730 5.69% | 2 215 2 006 10.4% | 713 781 -8.78% | 2 134 2 233 -4.44% | 935 1 249 -25.18% | 2 795 2 751 1.59% | 1 524 | 2 962 | 1 646 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 561 1 611 -3.09% | 1 011 1 007 0.44% | 2 251 1 843 22.14% | 712 746 -4.54% | 2 145 1 979 8.39% | 635 651 -2.35% | 1 963 | 2 379 2 778 -14.36% | ||||
Net income Million USD | Released Forecast Spread | 1 248 1 296 -3.7% | 855 805 6.15% | 1 810 1 447 25.09% | 565 508 11.15% | 1 760 1 523 15.59% | 494 521 -5.11% | 1 623 1 478 9.8% | 571 517 10.37% | 1 901 1 889 0.61% | 760 | 2 061 | 970 |
EPS USD | Released Forecast Spread | 2,74 2,89 -5.19% | 1,88 1,93 -2.85% | 3,98 3,17 25.55% | 1,23 1,22 1.23% | 3,85 3,29 17.14% | 0,96 1,09 -12.19% | 3,37 3,26 3.37% | 3,92 4,04 -2.85% | ||||
Announcement Date | 11/02/20 | 18/08/20 | 17/02/21 | 17/08/21 | 15/02/22 | 16/08/22 | 13/02/23 | 14/08/23 | 12/02/24 | - | - | - |
2024-07-11 02:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 02:00 | BIOGAIA AB: Q2 2024 Earnings Release |
2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-25 01:00 | UCB: Q2 2024 Earnings Release |
2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for CSL Limited
Today | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
2024-05-14 11:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
2024-05-09 16:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-09 16:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
2024-05-09 02:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
2024-05-08 16:16 | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CSL Stock
- CSLLY Stock
- Calendar CSL Limited